DataStreet
Nifty’s Volatility and Market Trends Ahead of Wednes...
Nifty saw a sudden 2% plunge then recovery during monthly expiry, amid global...
Rising Yields Pressure Gold and High-Yield Bond ETFs...
Higher interest rates push gold and high-yield bond ETFs lower, with traders ...
US 30-Year Treasury Yield Hits 5.61%, Highest Since ...
US 30-year Treasury yield climbs above 5.61%, reaching a two-decade high amid...
Citi Analyst Sees SpaceX's Starship Launch Paving Wa...
Citi highlights SpaceX's Starship launch as a key milestone that could drive ...
Netflix's Global Growth Offers Upside Despite U.S. M...
Deutsche Bank highlights Netflix's international gains as U.S. investor worri...
Infosys and Wipro Shares Hit Six-Year Lows Amid IT S...
Infosys and Wipro shares fall to six-year lows as IT sector faces pressure fr...
Vedanta Demerger Review: Mixed Performances Among Sp...
Three months post-demerger, Vedanta Aluminium, Iron & Steel, Power, and Oil &...
Gold Falls Below ₹1.5 Lakh per 10g in Delhi After Tw...
Gold price in Delhi drops below ₹1.5 lakh per 10 grams amid weak demand and s...
Google Pushes Back on EU Demands to Share AI and Sea...
Google resists European Union orders to grant rivals access to AI and search ...
Meta Expands Instagram School Program Amid Growing T...
Meta broadens its Instagram school program as scrutiny over teen safety incre...
Five Healthcare Stocks, Including Medico Remedies, H...
Five healthcare stocks, led by Medico Remedies, reached 52-week lows as Sense...
Nomura Highlights Earnings Strength but Flags Oil an...
Nomura projects solid earnings growth for India but warns oil prices and geop...
Centrum Initiates Buy on SBI Funds with 34% Upside T...
Centrum Broking recommends SBI Funds Management with a 34% upside, citing str...
Indian Government Bonds Gain as US Treasury Yields D...
Indian bonds rise following a selloff as US yields fall, influenced by US-Ira...
Transport Corp Approves Rs 150 Crore Share Buyback a...
Transport Corporation greenlights Rs 150 crore share buyback at 11% premium a...
Novo Nordisk Signs Second Licensing Deal After Inves...
Novo Nordisk secures second licensing agreement following investor concerns o...